Michael J Kerin Selected Research

ErbB-2 Receptor

1/2014	Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
6/2012	Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype.
9/2010	Dysregulated miR-183 inhibits migration in breast cancer cells.
1/2009	MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Kerin Research Topics

Disease

89	Breast Neoplasms (Breast Cancer) 08/2022 - 11/2007
58	Neoplasms (Cancer) 08/2022 - 05/2002
12	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 04/2010
5	Disease Progression 01/2022 - 09/2008
5	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2014
4	Triple Negative Breast Neoplasms 02/2019 - 06/2014
3	Carcinogenesis 01/2022 - 09/2010
2	Ductal Carcinoma 02/2022 - 10/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 11/2018
2	Familial Breast Cancer 11/2017 - 02/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016 - 08/2007
2	Prostatic Neoplasms (Prostate Cancer) 07/2015 - 01/2013
2	Fibroadenoma 05/2015 - 01/2011
2	Ovarian Neoplasms (Ovarian Cancer) 06/2014 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 12/2013 - 06/2013
1	Lobular Carcinoma 12/2022
1	Pathologic Complete Response 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Primary Hyperparathyroidism 01/2021
1	Appendicitis 12/2018
1	Rupture 12/2018
1	Infections 12/2018
1	Contracture 12/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Abdominal Pain (Pain, Abdominal) 07/2015
1	Pain (Aches) 07/2015
1	Genetic Risk Score 05/2015
1	Hypersensitivity (Allergy) 12/2013

Drug/Important Bio-Agent (IBA)

49	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2008
27	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2007
23	Estrogen ReceptorsIBA 12/2022 - 08/2009
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2009
11	Phenobarbital (Luminal)FDA Link 11/2021 - 01/2009
10	Epidermal Growth Factor (EGF)IBA 08/2022 - 04/2012
8	Hormones (Hormone)IBA 10/2021 - 12/2007
6	Progesterone Receptors (Progesterone Receptor)IBA 12/2022 - 12/2007
5	RNA (Ribonucleic Acid)IBA 04/2020 - 09/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2008
5	3' Untranslated Regions (3' UTR)IBA 01/2016 - 06/2012
4	Biological ProductsIBA 01/2019 - 11/2015
4	Estrogens (Estrogen)FDA Link 01/2015 - 12/2007
4	ErbB-2 ReceptorIBA 01/2014 - 01/2009
3	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2011
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
3	ChemokinesIBA 01/2012 - 01/2009
2	Circulating MicroRNAIBA 07/2020 - 07/2015
2	Trastuzumab (Herceptin)FDA Link 10/2017 - 07/2017
2	Untranslated RNA (Noncoding RNA)IBA 10/2016 - 05/2015
2	Messenger RNA (mRNA)IBA 05/2015 - 07/2013
2	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2015 - 01/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2015 - 01/2011
2	N 30IBA 05/2015 - 01/2013
2	Genetic Markers (Genetic Marker)IBA 05/2015 - 01/2012
2	LuciferasesIBA 06/2014 - 04/2013
2	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 10/2010
2	Progesterone FDA LinkGeneric 01/2009 - 12/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008 - 05/2002
2	Estrogen Receptor alphaIBA 01/2008 - 12/2007
1	Tamoxifen FDA LinkGeneric 08/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Syndecan-2IBA 01/2021
1	Parathyroid Hormone (Parathormone)IBA 01/2021
1	IodineIBA 01/2021
1	CollagenIBA 04/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2020
1	Carboplatin (JM8)FDA LinkGeneric 02/2019
1	PlatinumIBA 02/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 11/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2017
1	Tyrosine Kinase InhibitorsIBA 04/2017
1	Dasatinib (BMS 354825)FDA Link 04/2017
1	src-Family KinasesIBA 04/2017
1	Nucleosomes (Nucleosome)IBA 01/2017
1	Histones (Histone)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 07/2015
1	A-factor (Streptomyces)IBA 05/2015
1	RetinoidsIBA 05/2015
1	human ERBB2 proteinIBA 03/2015
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2015
1	ChromatinIBA 01/2015
1	Deoxyribonucleases (DNase)FDA Link 12/2013
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2013
1	Plasminogen Activator Inhibitor 1IBA 06/2013
1	Complement System Proteins (Complement)IBA 06/2013
1	Cyclin D1IBA 04/2013
1	ParaffinIBA 02/2013
1	Formaldehyde (Formol)FDA Link 02/2013

Therapy/Procedure

21	Therapeutics 12/2022 - 12/2007
12	Neoadjuvant Therapy 02/2022 - 05/2010
9	Drug Therapy (Chemotherapy) 01/2022 - 02/2014
4	Mammaplasty (Breast Reconstruction) 08/2022 - 01/2017
4	Mastectomy (Mammectomy) 01/2021 - 08/2007
3	Radiotherapy 10/2021 - 07/2010
3	Adjuvant Chemotherapy 01/2021 - 02/2019
1	Parathyroidectomy 01/2021
1	Thyroidectomy 11/2018
1	Analgesia 07/2015
1	Length of Stay 07/2015